News · 26 weeks10%
2025-12-142026-06-07
Mix090d
No activity.
Latest news
25 items- PRDiality Appoints Peter Donato as Chief Financial OfficerLife sciences veteran brings private and public sector expertise to company in midst of growth trajectory Diality Inc., a medical device company that has developed the Moda-flx™ Hemodialysis System, today announced it has named Peter Donato as its chief financial officer. Donato joins the company as it continues to enroll patients in the PRESCRIBE Diality Home Hemodialysis Clinical Trial of its Moda-flx Hemodialysis System while preparing for a limited market release in 2027. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260224064413/en/Diality CFO Peter Donato. Donato joins Diality with nearly 35 years of financial leadershi
- NEWSZomedica Announces Collaboration with Prime Video as Assisi Loop(R) Products Appear in New Holiday Film MervThe collaboration highlights Zomedica's commitment to expanding pet wellness education as Assisi Loop technology is featured in the highly anticipated movie Merv now available on Prime Video ANN ARBOR, MI / ACCESS Newswire / December 11, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative diagnostic and therapeutic devices for equine and companion animals, is thrilled to announce that its Assisi® and Calmer Canine® products are featured in the new romantic comedy Merv, available now on Prime Video.Zomedica Brings Real Pet Wellness Technology to the Big ScreenIn an exciting collaboration with Prime Video, Zomedica's Assisi and Calmer
- NEWSZomedica Expands TRUFORMA(R) Diagnostic Menu with Launch of Equine Progesterone AssayNewest assay expands TRUFORMA market opportunity by building on endocrinology foundation to address reproductive health in the equine segment ANN ARBOR, MI / ACCESS Newswire / December 4, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative point-of-care diagnostic and therapeutic device products for equine and companion animals, today announced the expansion of its TRUFORMA platform with the launch of its equine progesterone assay, designed as a powerful reproductive management tool to support breeding programs, pregnancy monitoring, and improved outcomes for horse owners."By introducing the TRUFORMA Progesterone assay, we are exten
- NEWSZomedica Announces "Friday at Four" Webinar on November 21st Providing Strategic Overview & Third Quarter 2025 Business ReviewNovember session to provide strategic context for Zomedica's product platforms featured in the previous Fourth Friday at Four Webinars ANN ARBOR, MI / ACCESS Newswire / November 11, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative diagnostic and therapeutic devices for equine and companion animals, today announced a special session of its "Fourth Friday at Four" investor webinar series. To accommodate the holiday calendar, this month's webinar will be held on the third Friday-November 21, 2025 at 4:00 p.m. Eastern Time.The November program will provide a comprehensive overview of Zomedica's strategy-to-date, a review of third-qua
- NEWSZomedica Achieves ISO 13485 Certification, Underscoring Strengthened Quality Infrastructure and Commercial PotentialCertification enhances global market readiness, reinforces quality systems, and supports Zomedica's long-term growth strategy ANN ARBOR, MI / ACCESS Newswire / November 6, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative point-of-care diagnostic and therapeutic device products for equine and companion animals, today announced that it has earned ISO 13485:2016 certification for its manufacturing and distribution operations in Plymouth, Minnesota and Roswell, Georgia. This milestone further cements Zomedica's commitment to quality, compliance, and global market readiness.Certification Highlights & Operational ImpactISO 13485 is an
- NEWSZomedica Announces Third Quarter 2025 Financial Results: Revenue up 16% to $8.1 Million with 67% Gross Margins and $54 Million in Liquidity to Support GrowthZomedica posts highest quarterly revenue ever and record year-over-year revenue for 19th straight quarter! ANN ARBOR, MI / ACCESS Newswire / November 4, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, today reported consolidated financial results for the third quarter ended September 30, 2025."Delivering 16% growth and achieving record year-over-year revenue for the 19th straight quarter demonstrates the consistency and resilience of our business. Crossing $8 million in quarterly sales for the first time is a proud moment for our company and a clear indicat
- NEWSZomedica Announces Launch of the Assisi Loop Lounge(R), Scientifically Backed tPEMF(TM) Therapy for PetsCombining peer-reviewed science, superior comfort, and thoughtful design, the Assisi Loop Lounge expands Zomedica's evidence-based therapeutic portfolio and reinforces Assisi's leadership in targeted tPEMF innovation ANN ARBOR, MI / ACCESS Newswire / October 23, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative point-of-care diagnostic and therapeutic products for equine and companion animals, today announced the launch of the Assisi Loop Lounge, a next-generation targeted pulsed electromagnetic field (tPEMF) therapy bed delivering full-body treatment and luxurious comfort for pets, now featuring unlimited uses and a lifetime warr
- NEWSZomedica Expands Grovet's Distribution Agreement to Include Zomedica's Diagnostic and Therapeutic Device Products Across the European UnionExpanded agreement strengthens Zomedica's European presence, broadens product portfolio on the market, and positions the Company to capture growth in the multi-billion-dollar global veterinary diagnostics and therapeutic device markets ANN ARBOR, MI, MI / ACCESS Newswire / October 14, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative point-of-care diagnostic and therapeutic device products for equine and companion animals, today announced that it has entered into an expanded distribution agreement with Grovet b.v., a leading equine health company based in the Netherlands. The amended agreement expands Grovet's existing distributio
- NEWSZomedica to Spotlight VETGuardian(R) Zero Touch(TM) Monitor in October "Fourth Friday at Four" WebinarLive session on October 24th will showcase how the VETGuardian Monitor enhances patient care, improves workflow efficiency, and expands global market opportunities ANN ARBOR, MI, MI / ACCESS Newswire / October 9, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering innovative point-of-care diagnostic and therapeutic device products for equine and companion animals, today announced that its upcoming "Fourth Friday at Four" webinar series, to be held on October 24, 2025 at 4:00 p.m. ET, will feature a deep dive into Zomedica's VETGuardian Zero Touch monitoring platform.Key Learning PointsMarket Expansion Opportunity: The veterinary monitoring
- NEWSZomedica Expands TRUFORMA(R) Diagnostic Platform with Addition of Feline Use to Cobalamin & Folate AssayFirst and only in-clinic multiplexed Cobalamin & Folate assay now validated for feline patients ANN ARBOR, MI / ACCESS Newswire / September 23, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering innovative point-of-care diagnostic and therapeutic device products for equine and companion animals, today announced the expansion of its TRUFORMA diagnostic platform with the addition of feline testing capability to its cobalamin & folate assay.Originally launched in early 2024 for canine use, this multiplexed assay-combining two critical tests in one-was the first of its kind to bring both cobalamin and folate testing to the in-clinic setting. S
- NEWSZomedica Expands TRUVIEW(R) and TRUFORMA(R) Intellectual Property Portfolio with Four Newly Issued U.S. PatentsIntellectual property portfolio now includes 228 Patents and 153 Trademarks providing robust protection for the Company's product platforms in the rapidly growing multi-billion dollar veterinary diagnostics market ANN ARBOR, MI / ACCESS Newswire / September 18, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative point-of-care diagnostic and therapeutic device products for equine and companion animals, today announced the issuance of four additional U.S. patents protecting its TRUVIEW and TRUFORMA diagnostic platforms.These new patents significantly strengthen Zomedica's intellectual property portfolio and enhance the Company's abili
- NEWSZomedica's Fourth Friday at Four Webinar Returns: Spotlight on TRUVIEW(R) Digital Cytology Microscope - Transforming Veterinary ImagingCutting-Edge Digital Microscopy System Featured in Monthly Series Showcasing Innovation in Veterinary Care ANN ARBOR, MI / ACCESS Newswire / September 12, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering advanced diagnostic and therapeutic solutions for companion and equine animals, is pleased to announce the next installment of its Fourth Friday at Four webinar series, scheduled for Friday, September 26 at 4:00 PM ET, featuring the TRUVIEW digital cytology microscope.This month's feature will highlight how the TRUVIEW microscope is redefining digital cytology and hematology in veterinary practice by providing rapid, high-quality image c
- NEWSZomedica and UXR Announce Expanded Distribution Agreement in CanadaAgreement strengthens Canadian veterinarians' access to Zomedica's advanced therapeutic and monitoring solutions ANN ARBOR, MI / ACCESS Newswire / September 10, 2025 / Zomedica Corp. (OTCQB:ZOMDF), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, announced today that it has expanded its distribution agreement with UXR Inc., a leading Canadian animal health company focused on supporting the needs of veterinarians across Canada.Under the expanded agreement, UXR will become:Exclusive distributor of Zomedica's PulseVet® system in Canada and co-exclusive distributor of the system's consumable Trode accessories.Exclusive distr
- NEWSZomedica Strengthens UK Market Position with Strategic Distribution Agreement for High-Growth Veterinary Innovation PortfolioStrategic partnership with Pioneer Veterinary Products Limited expands Zomedica's presence in the UK veterinary market through distribution of its leading point-of-care solutions ANN ARBOR, MI / ACCESS Newswire / September 3, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, today announced a new distribution partnership in the United Kingdom with Pioneer Veterinary Products Limited, one of the region's most respected veterinary distributors. The agreement begins with the distribution of Zomedica's TRUFORMA® diagnostic platform throughout England, Scotland
- NEWSZomedica and VerticalVet Announce Strategic Partnership to Deliver Advanced Veterinary Technologies to Independent PracticesNew agreement brings innovative shock wave, tPEMF therapy, monitoring, and bleeding control solutions to more than 2,200 member clinics nationwide ANN ARBOR, MI / ACCESS Newswire / August 19, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering advanced diagnostic and therapeutic solutions for companion and equine animals, announced today a new strategic partnership with VerticalVet, one of the veterinary industry's most respected Group Purchasing Organizations (GPOs), supporting over 2,600 independent veterinary practices across the United States. This two-year agreement establishes Zomedica as a preferred provider of advanced veterinary so
- NEWSZomedica's Fourth Friday at Four Webinar Returns: Spotlight on the VETIGEL(R) Hemostatic Product - The Future of Rapid Bleeding Control in Veterinary MedicineRevolutionary Plant-Based Technology Gains Momentum as a Game-Changer in Wound Management ANN ARBOR, MI / ACCESS Newswire / August 12, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering advanced diagnostic and therapeutic solutions for equine and companion animals, is pleased to announce the next installment of its Fourth Friday at Four webinar series, scheduled for Friday, August 22, 2025, at 4:00 PM ET.This month's session will highlight VETIGEL® hemostatic gel, Zomedica's innovative, plant-based solution designed for rapid and effective control of bleeding. The VETIGEL product provides veterinary professionals a fast, easy-to-use option
- NEWSZomedica Announces Second Quarter 2025 Financial Results: Revenue up 14% to $7 Million with 67% Gross Margins and $59 Million in Liquidity to Support GrowthZomedica posts record year-over-year revenue for 18th straight quarter! ANN ARBOR, MI / ACCESS Newswire / August 6, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, today reported consolidated financial results for the second quarter ended June 30, 2025."We are very pleased with the 14% growth attained in the second quarter as we posted record year-over-year revenue for the 18th straight quarter," said Larry Heaton, Chief Executive Officer of Zomedica. "Bolstered by continued and robust usage of our therapeutic products, including our PulseVet® and Assisi
- NEWSZomedica's Fourth Friday at Four Webinar Returns: Spotlight on the Assisi(R) Line - Advancing Drug-Free Healing for PetsBreakthrough tPEMF™ Technology Showcased in Monthly Series Exploring Innovation in Veterinary Care ANN ARBOR, MI / ACCESS Newswire / July 16, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering advanced diagnostic and therapeutic solutions for companion and equine animals, is pleased to announce the next installment of its Fourth Friday at Four webinar series, scheduled for Friday, July 25, 2025 at 4:00 PM ET.This month's session will highlight the Assisi line of products, Zomedica's suite of targeted Pulsed Electromagnetic Field (tPEMF) therapy devices that offer non-invasive, drug-free solutions for managing pain and inflammation in compa
- NEWSZomedica Announces Strategic PulseVet(R) Shock Wave Partnership with World Equestrian Center – OcalaElevating Equine Health and Show Experience with Leading Shock Wave Therapy ANN ARBOR, MI / ACCESS Newswire / July 10, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, today announced a strategic sponsorship agreement between its leading brand, the PulseVet shock wave device, and the World Equestrian Center - Ocala (WEC), one of the premier equestrian venues in the world. This partnership designates the PulseVet device as the official shock wave therapy provider at WEC - Ocala, enhancing veterinary care for elite equine athletes and reinforcing Zomedica's
- NEWSZomedica Announces Issuance of Additional Patent for its TRUVIEW(R) MicroscopeIntellectual Property Portfolio grows to 221 Patents and 140 Trademarks ANN ARBOR, MI / ACCESS Newswire / June 24, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced the issuance of a new patent related to its TRUVIEW microscope and provided an update on the Company's current intellectual property portfolio.The U.S. Patent related to the TRUVIEW microscope, manufactured, sold and distributed by Zomedica, was U.S. Patent No. 12,299,917 B2 issued recently for the Methods and Systems for Slide Imaging Calibration.Bill Campbell, Zomedica's Vice
- NEWSZomedica's Fourth Friday at Four Webinar Returns: Spotlight on TRUFORMA Diagnostic Platform(R) - Revolutionizing In-Clinic DiagnosticsNext-Generation Diagnostic Platform Takes Center Stage in Monthly Series Showcasing Innovation in Veterinary Care ANN ARBOR, MI / ACCESS Newswire / June 19, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic device products for equine and companion animals, is pleased to announce the next installment of its Fourth Friday at Four webinar series, scheduled for Friday, June 27 at 4:00 PM ET featuring the TRUFORMA diagnostic platform.This month's feature will dive deep into the TRUFORMA diagnostic platform, Zomedica's game-changing in-clinic system that is setting new standards in point-of-care veterina
- NEWSZomedica Launches Enhanced Equine Insulin Assay for the TRUFORMA(R) Diagnostic Platform Featuring an Extended Range and Automatic Sample DilutionThe TRUFORMA Platform now has the widest dynamic range (without manual dilution) available either at the Point of Care or from a Reference Lab ANN ARBOR, MI / ACCESS Newswire / May 21, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced an update to one of their fastest growing assays, insulin for equine plasma. This update increases the test's already industry-leading point of care dynamic range and adds a new function, automatic sample dilution, that allows a veterinarian to measure insulin at the highest levels with no additional steps or
- NEWSZomedica Unveils Exclusive Fourth Friday at Four Webinar Series to Explore Cutting-Edge Veterinary InnovationsEngaging Sessions to Highlight Game-Changing Technologies, Expert Insights, and Growth Opportunities in Animal Health Featuring Zomedica Products ANN ARBOR, MI / ACCESS Newswire / May 19, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, today announced the launch of a new monthly webinar series designed to highlight its innovative product portfolio, introduce key personnel, showcase manufacturing capabilities, and educate investors and strategic partners on the company's long-term growth strategy.This exclusive webinar series scheduled for the fourth Frid
- NEWSZomedica Launches Groundbreaking Equine Asthma Clinical Registry Featuring PulseVet(R) Shock Wave TherapyInnovative Registry Harnesses Shock Wave Therapy to Advance Non-Drug Equine Asthma Treatment and Drive Evidence-Based Veterinary Care ANN ARBOR, MI / ACCESS Newswire / May 13, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, today announced the launch of the Equine Asthma Clinical Registry. This pioneering program leverages PulseVet® shock wave therapy to offer a non-invasive, drug-free treatment alternative for horses suffering from asthma.Equine asthma is a common yet often underdiagnosed condition, affecting an estimated 15% of horses over the age of s
- INSIDERAmendment: Director Rowe Jeffrey M bought $96,098 worth of shares (1,439,005 units at $0.07) (SEC Form 4)4/A - Zomedica Corp. (0001684144) (Issuer)
ZOM FAQ
7 questionsWhat does Zomedica Corp. do?
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA, a diagnostic biosensor platform for the detection of thyroid disorders in dogs and cats, and adrenal disorders in dogs. It has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for development and commercialization of...Where does ZOM stock trade?
Zomedica Corp. (ZOM) is listed on AMEX.What sector and industry is ZOM in?
Zomedica Corp. operates in the Health Care sector, Pharmaceuticals and Biotechnology industry.When did Zomedica Corp. go public?
Zomedica Corp. (ZOM) completed its IPO in 2017.What are analysts saying about ZOM?
Zomedica Corp. has had 1 recent analyst action on file. The most recent action was from Dawson James: Buy with a $600.00 price target on 2023-01-06. Recent price targets cluster around $600.00.What companies are similar to ZOM?
Notable peers in the same industry include EPRX (Eupraxia Pharmaceuticals Inc.), HEXO (HEXO Corp.), RVLP (RVL Pharmaceuticals plc), IMV (IMV Inc.), NVCN (Neovasc Inc.). Compare ZOM side-by-side with any of them on Quantisnow.How can I track ZOM on Quantisnow?
Quantisnow aggregates Zomedica Corp.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ZOM to receive live email and push alerts on every new disclosure.